Dapiglutide
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Zealand Pharma · Phase 1 · Completed · Enrollment 30
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Dapiglutide 10 mg/mL | n/r | n/r | n/r | n/r | n/r |
| Dapiglutide 25 mg/mL | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.